Event Type
Disclosure
Voluntary
Variant
8-K
. Other Events. On July 9, 2025, Lixte Biotechnology Holdings, Inc. (the “Company”) issued a press release announcing that the Medical Journal Nature published
. Financial Statements and Exhibits. (d) There is filed as part of this report the exhibits listed on the accompanying Index to Exhibits, which exhibits are inc